Similar Articles
271 Can visceral fat parameters based on computed tomography be used to predict occult peritoneal metastasis in gastric cancer?
272 Advances in translational therapy for locally advanced gastric cancer
273 Current trends in perioperative treatment of resectable gastric cancer
274 Endoscopic advances in the management of gastric cancer and premalignant gastric conditions
275 F-box and leucine-rich repeat 6 promotes gastric cancer progression via the promotion of epithelial-mesenchymal transition
276 Comparison of genomic and transcriptional microbiome analysis in gastric cancer patients and healthy individuals
277 Endoscopic fluorescent lymphography for gastric cancer
278 Evaluation of polygenic risk score for risk prediction of gastric cancer
279 Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
280 Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA